Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Goodwill (2021 - 2023)

InMed Pharmaceuticals' Goodwill history spans 3 years, with the latest figure at $1.1 million for Q2 2023.

  • For Q2 2023, Goodwill fell 5.79% year-over-year to $1.1 million; the TTM value through Jun 2023 reached $1.1 million, down 5.79%, while the annual FY2023 figure was $1.1 million, 5.79% down from the prior year.
  • Goodwill reached $1.1 million in Q2 2023 per INM's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $2.0 million in Q4 2021 to a low of $1.1 million in Q2 2023.
  • Average Goodwill over 3 years is $1.6 million, with a median of $1.6 million recorded in 2021.
  • The largest YoY upside for Goodwill was 5.79% in 2023 against a maximum downside of 5.79% in 2023.
  • A 3-year view of Goodwill shows it stood at $2.0 million in 2021, then plummeted by 43.47% to $1.1 million in 2022, then fell by 5.79% to $1.1 million in 2023.
  • Per Business Quant, the three most recent readings for INM's Goodwill are $1.1 million (Q2 2023), $1.1 million (Q2 2022), and $2.0 million (Q1 2022).